FHIR
© HL7.org |
Server Home
|
XIG Home
|
Server Source
|
FHIR
FHIR IG Statistics: FHIR Resources
Version:
All
|
R2
|
R2B
|
R3
|
R4
|
R4B
|
R5
|
R6
Authority:
All
|
hl7
|
ihe
|
national
Realm:
All
|
BNW
|
au
|
be
|
br
|
ca
|
ch
|
cl
|
cr
|
cz
|
de
|
dk
|
ee
|
eu
|
fi
|
fr
|
il
|
in
|
it
|
jp
|
nl
|
no
|
nz
|
pt
|
se
|
sl
|
stt
|
tw
|
uk
|
us
|
uv
|
vn
View:
All
|
Resource Profiles
|
Datatype Profiles
|
Extensions
|
Logical Models
|
CodeSystems
|
ValueSets
|
ConceptMaps
Resources - All Kinds, Realm US
18,284 resources
Type:
ActivityDefinition
ActorDefinition
CapabilityStatement
CodeSystem
ConceptMap
ExampleScenario
GraphDefinition
ImplementationGuide
Measure
MessageDefinition
NamingSystem
OperationDefinition
PlanDefinition
Questionnaire
Requirements
SearchParameter
StructureDefinition
StructureMap
TerminologyCapabilities
TestScript
ValueSet
Text:
By Version
R2
: 52
R2B
: 0
R3
: 523
R4
: 17,269
R4B
: 0
R5
: 440
R6
: 0
By Authority
none: 1,998
hl7
: 16,284
national
: 2
Start
Prev
Rows 6400 - 6600
Next
Package
Version
Identity
Name/Title
Status
FMM
WG
Date
Auth
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.727
Tetracycline Allergy SCT
active
2023-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.728
Tetracycline Allergy Intolerance
active
2023-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.729
Fluoroquinolones Allergy SCT
active
2023-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.730
Fluoroquinolone Allergy Intolerance
active
2023-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.731
Penicillin Allergy RXNORM
active
2023-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.732
Penicillin Allergy SCT
active
2023-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.733
Penicillin Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.734
PIM_Metformin_Single_Ingredient_Only
active
2023-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.735
PIM_Metformin_Combo_Ingredient_Only
active
2023-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.737
Pneumonia SCT
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.738
Pneumonia
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.739
Pulmonary Embolism I10
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.742
Pulmonary Embolism SCT
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.743
Pulmonary Embolism
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.744
Influenza I10
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.745
Influenza SCT
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.746
Influenza (Tests for influenza A or B virus Antigen)
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.747
Influenza
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.748
COVID 19 I10
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.749
COVID19 SCT
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.750
COVID19
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.752
RSV I10
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.753
RSV SCT
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.754
RSV
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.755
Respiratory Rate SCT
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.756
Respiratory Rate LOINC
active
2024-09
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.757
Respiratory Rate
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.758
Acute Respiratory Failure I10
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.759
Acute Respiratory Failure SCT
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.760
Acute Respiratory Failure
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.761
Dyspnea SCT
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.762
Dyspnea I10
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.763
Dyspnea
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.764
Confusion I10
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.765
Confusion SCT
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.766
Confusion
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.767
Drowsiness SCT
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.768
Drowsiness I10
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.769
Drowsiness
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.770
Cyanosis I10
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.771
Cyanosis SCT
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.772
Cyanosis
active
2023-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.775
Arterial oxygen saturation LOINC
active
2024-09
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.776
Arterial oxygen saturation SCT
active
2024-08
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.777
Arterial oxygen saturation
active
2024-08
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.779
PIM_Potassium_Supplements
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.780
PIM_PPIs
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.781
PIM_Migraine_Medications_Abortive
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.782
PIM_Migraine_Medications_Preventive
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.783
PIM_Bisphosphonates
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.784
PIM_BPH_Medications
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.785
PIM_Thyroid_Replacement_Medications
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.786
PIM_Overactive_Bladder_Medications
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.787
PIM_Topical_Acne_Medications
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.788
PIM_Antidepressant_Anxiolytic_Medications
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.789
Simple Knee Pain I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.790
Simple Knee Pain SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.791
Simple Knee Pain
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.792
Simple Left Knee Pain SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.793
Simple Right Knee Pain SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.794
Simple Right Knee Pain I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.795
Simple Left Knee Pain I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.796
Simple Right Knee Pain
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.797
Simple Left Knee pain
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.798
Knee joint surgery CPT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.799
Knee joint surgery SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.800
Knee joint surgery
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.801
Knee Osteoarthritis I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.802
Knee Osteoarthritis SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.803
Knee Osteoarthritis
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.804
Osteoarthritis of right knee SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.805
Osteoarthritis of left knee SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.806
Osteoarthritis of right knee I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.807
Osteoarthritis of left knee I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.808
Osteoarthritis of right knee
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.809
Osteoarthritis of left knee
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.810
Hip Osteoarthritis SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.811
Hip Osteoarthritis I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.812
Hip Osteoarthritis
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.813
Hip joint surgery CPT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.814
Hip joint surgery SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.815
Hip joint surgery
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.816
Osteoarthritis of right hip I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.817
Osteoarthritis of left hip I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.818
Osteoarthritis of right hip SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.819
Osteoarthritis of left hip SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.820
Osteoarthritis of right hip
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.821
Osteoarthritis of left hip
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.823
Aminoglycosides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.824
Carbapenems
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.826
Monobactams
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.827
Penicillins
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.828
Antimycobacterials
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.829
Beta_lactamase
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.830
Cyclic lipopeptides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.831
Lincosamides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.832
Macrolides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.833
Amphenicol
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.834
Oxazolidinones
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.835
Fluoroquinolones
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.836
Sulfonamides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.837
Tetracyclines
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.838
Phosphonics
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.839
Pleuromutilin
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.840
Streptogramins
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.841
Lipoglycopeptides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.842
Nitroimidazoles
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.843
PIM_Hyd_Bus_Mir_Tra
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.844
Nitrofurans
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.845
Rifamycins
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.846
Glycylcycline
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.847
Pyrimidines
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.849
Antibiotics oral and parenteral
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.850
Medications_hyperkalemia
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.852
Hyperkalemia_ICD10
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.853
Hyperkalemia_SCT
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.854
Hyperkalemia Conditions
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.855
Medications_Chronic Hyperkalemia
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.858
PIM_Alpha_Blockers_2
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.860
PIM_Ambulatory_Visits_CPTs
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.862
PIM_Ambulatory_Visits_SNOMED
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.863
PIM_Thyroid_Stimulating_Hormone_(TSH)
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.864
PIM_Triiodothyronine_(T3)
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.865
PIM_Thyroxine_(T4)
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.866
PIM_Magnesium_LOINC
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.867
PIM_BMP_CMP_LOINC
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.868
PIM_URIC_ACID_LOINC
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.869
PIM_Migraine_Medications
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.870
PIM_Triptans
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.871
ICS_SABA Reliever
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.873
PIM_Asthma_COPD_Meds
active
2025-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.874
PIM_Lipid_Panel_CPTs
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.875
PIM_Hepatic_Function_Panel_CPTs
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.876
Alpha Glucosidase Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.877
Inflammatory bowel disease I10
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.878
Inflammatory bowel disease SCT
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.879
Inflammatory bowel disease
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.880
Gastrointestinal obstruction SCT
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.881
Gastrointestinal obstruction I10
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.882
Gastrointestinal obstruction
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.883
DPP4i Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.884
Multiple endocrine neoplasia type 2 (MEN II) SCT
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.885
Multiple endocrine neoplasia type 2 (MEN II) I10
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.886
Multiple endocrine neoplasia type 2 (MEN II)
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.887
Gastroparesis SCT
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.888
Gastroparesis I10
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.889
Gastroparesis
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.890
Meglitinide Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.891
Sulfonylurea Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.892
Peripheral edema I10
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.893
Peripheral edema SCT
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.894
Peripheral edema
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.895
TZD Allergy Intolerance
active
2025-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.896
PIM_Beta_Blockers
active
2024-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.897
PIM_CCB_DHPs
active
2024-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.898
PIM_Loop_Diuretics
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.899
PIM_Inhaled_Corticosteroids_(ICS)
active
2025-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.9
ACE inhibitors
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.90
ASCVD I10
active
2023-09
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.900
PIM_Leukotrienes
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.901
OIA_Asthma_COPD_Meds_Inhalers
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.902
OIA_Asthma_COPD_Meds_Nebulizers
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.903
OIA_Asthma_COPD_Meds_Oral
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.904
OIA_GLP1_Injectables
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.905
OIA_Insulin_Injectables
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.906
OIA_Oral_Hypoglycemics
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.907
OIA_DM1_DM2_Meds
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.908
Medium Dose ICS Formoterol
active
2024-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.909
High Dose ICS Formoterol
active
2024-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.910
CKD stage5OrESRD I10
active
2024-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.911
CKD stage5OrESRD SCT
active
2024-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.912
CKD stage5OrESRD
active
2024-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.914
Anxiety_I10
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.915
Anxiety_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.916
Anxiety
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.918
Stress_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.919
Stress_I10
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.920
Stress
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.921
PBH_Anxiety_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.922
PBH_Depression_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.923
PBH_Stress_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.924
PBH_Insomnia_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.925
PIM_CMP_CPTs
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.926
Canagliflozin meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.927
Empagliflozin meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.928
Dapagliflozin meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.929
Ertugliflozin meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.930
Dulaglutide meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.931
Liraglutide meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.932
Semaglutide SC meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.933
T2DM meds benefitting ASCVD
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.934
T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.935
T2DM meds benefitting CKD stage 5
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.936
T2DM meds benefitting HF with eGFR >= 20 mL/min
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.938
Crohn disease SCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.939
Crohn disease I10
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.940
Crohn disease
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.941
Celiac disease SCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.942
Celiac disease I10
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.943
Celiac disease
active
2024-10
hl7